Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8P2E

Homotypic interacting B1 fab bound to Chondroitin Sulfate A

8P2E の概要
エントリーDOI10.2210/pdb8p2e/pdb
EMDBエントリー17362
分子名称B1 fab light, B1 fab heavy (2 entities in total)
機能のキーワードchondroitin sulfate a, sugar binding protein
由来する生物種Homo sapiens
詳細
タンパク質・核酸の鎖数8
化学式量合計200327.50
構造登録者
Raghavan, S.S.R.,Dagil, R.,Wang, K.T.,Salanti, A. (登録日: 2023-05-16, 公開日: 2024-06-05, 最終更新日: 2025-07-02)
主引用文献Vidal-Calvo, E.E.,Martin-Salazar, A.,Choudhary, S.,Dagil, R.,Raghavan, S.S.R.,Duvnjak, L.,Nordmaj, M.A.,Clausen, T.M.,Skafte, A.,Oberkofler, J.,Wang, K.,Agerbaek, M.O.,Loppke, C.,Jorgensen, A.M.,Ropac, D.,Mujollari, J.,Willis, S.,Garcias Lopez, A.,Miller, R.L.,Karlsson, R.T.G.,Goerdeler, F.,Chen, Y.H.,Colaco, A.R.,Wang, Y.,Lavstsen, T.,Martowicz, A.,Nelepcu, I.,Marzban, M.,Oo, H.Z.,Orum-Madsen, M.S.,Wang, Y.,Nielsen, M.A.,Clausen, H.,Wierer, M.,Wolf, D.,Gogenur, I.,Theander, T.G.,Al-Nakouzi, N.,Gustavsson, T.,Daugaard, M.,Salanti, A.
Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate.
Nat Commun, 15:7553-7553, 2024
Cited by
PubMed Abstract: Molecular similarities between embryonic and malignant cells can be exploited to target tumors through specific signatures absent in healthy adult tissues. One such embryonic signature tumors express is oncofetal chondroitin sulfate (ofCS), which supports disease progression and dissemination in cancer. Here, we report the identification and characterization of phage display-derived antibody fragments recognizing two distinct ofCS epitopes. These antibody fragments show binding affinity to ofCS in the low nanomolar range across a broad selection of solid tumor types in vitro and in vivo with minimal binding to normal, inflamed, or benign tumor tissues. Anti-ofCS antibody drug conjugates and bispecific immune cell engagers based on these targeting moieties disrupt tumor progression in animal models of human and murine cancers. Thus, anti-ofCS antibody fragments hold promise for the development of broadly effective therapeutic and diagnostic applications targeting human malignancies.
PubMed: 39215044
DOI: 10.1038/s41467-024-51781-0
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (3.2 Å)
構造検証レポート
Validation report summary of 8p2e
検証レポート(詳細版)ダウンロードをダウンロード

251801

件を2026-04-08に公開中

PDB statisticsPDBj update infoContact PDBjnumon